Regeneron Pharmaceuticals, Inc.

WEDGE CAPITAL MANAGEMENT L L P/NC REGN

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/14/2026

Shares

41,302

Value ($000)

31,880

Weight

0.6%

2025 Q3 - 2025 Q4 (2 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/14/2026	31,880	0.6%	41,302	12/31/2025
2025 Q3	10/10/2025	25,412	0.4%	45,195	9/30/2025